When will Intellia Therapeutics submit a BLA for Lonvo-z?

Prediction market on kalshi. If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Jan 1, 2027, then the market resolves to Yes.

Liquidity: $75. Resolves: 1/8/2027.